This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Siro Serafini: Innovator in Asymmetric Synthesis
Introduction
Siro Serafini is a notable inventor based in Vincenza, Italy. He has made significant contributions to the field of chemistry, particularly in the synthesis of piperazic acid and its derivatives. His innovative approach has implications for pharmacological applications, showcasing the importance of his work in the scientific community.
Latest Patents
Siro Serafini holds a patent for the "Asymmetric synthesis of piperazic acid and derivatives thereof." This invention provides a concise, asymmetric synthesis of piperazic acid, allowing for the production of either the (3S)- or (3R)-enantiomeric form with high optical purity. The method utilizes D-glutamic acid as a starting material, leading to the formation of (3S)-piperazic acid through an (R)-2,5-dihydroxyvalerate ester intermediate. The process is designed to be efficient and effective, making it a valuable contribution to the field.
Career Highlights
Siro Serafini is currently associated with Vertex Pharmaceuticals, Inc., where he continues to apply his expertise in chemistry. His work focuses on developing methods that can lead to the creation of pharmacologically active compounds. The significance of his research is underscored by the potential applications of the piperazic acid derivatives he has developed.
Collaborations
Siro has collaborated with esteemed colleagues such as Stefania Leonardi and Petra Dieterich. These partnerships have likely enhanced the scope and impact of his research, fostering an environment of innovation and discovery.
Conclusion
Siro Serafini's contributions to the field of asymmetric synthesis highlight his role as an influential inventor. His patent on piperazic acid synthesis not only showcases his innovative spirit but also emphasizes the potential for his work to impact pharmacological advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
